Serotonin antagonism in primate experimental myocardial infarction
| dc.contributor.author | Hartford, Craig Gordon | |
| dc.date.accessioned | 2018-04-18T10:23:26Z | |
| dc.date.available | 2018-04-18T10:23:26Z | |
| dc.date.issued | 1992-10-07 | |
| dc.description | A Dissertation submitted to the Faculty of Medicine, University of the Witwatersrand, Johannesburg, for the Degree of Master of Science. | en_ZA |
| dc.description.abstract | Serotonin (5-Hydroxytryptamine, 5-HT) mediates vasoconstriction and vasodilation in the normal coronary circulation of various animal species. In the presence of coronary artery disease serotonin may inhibit coronary collateral formation and stimulate predominantly vasoconstriction. This study tested the effect of ketanserin, a selective 5-HT2 receptor antagonist and platelet aggregation inhibitor, on ischaemic myocardium blood flow and coronary collateral formation following coronary artery occlusion in primates. | en_ZA |
| dc.description.librarian | IT2018 | en_ZA |
| dc.identifier.uri | https://hdl.handle.net/10539/24363 | |
| dc.language.iso | en | en_ZA |
| dc.subject.mesh | Serotonin | |
| dc.subject.mesh | Drug Antagonism | |
| dc.subject.mesh | Myocardial Infarction | |
| dc.title | Serotonin antagonism in primate experimental myocardial infarction | en_ZA |
| dc.type | Thesis | en_ZA |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Craig Gordon Hartford.pdf
- Size:
- 46.54 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: